dr. shuch on considerations for appropriate treatment in advanced rcc
Published 5 years ago • 347 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
2:15
dr. shuch on the impact of the surtime trial in advanced rcc
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:50
dr. shuch on role of cytoreductive nephrectomy in rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
1:18
dr. figlin on treatment strategies in advanced rcc
-
1:00
dr. vaishampayan on the potential of tivozanib in advanced rcc
-
0:59
dr. lee on second-line treatment options in rcc
-
8:34
promising treatments in advanced rcc
-
1:15
dr. vaishampayan on the safety of tivozanib versus sorafenib in rcc
-
6:46
treatment considerations in renal cell carcinoma
-
1:41
dr. choueiri on next steps for treatment in rcc
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
0:51
dr. schmidinger on managing side effects from targeted therapies in rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
6:07
goals of therapy in advanced rcc
-
8:10
choosing among tkis in advanced rcc
-
1:11
dr. zhang on toxicities of treatments in rcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc